Skip to content

Clinical trials

Phase 2 Diabetic Nephropathies trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Phase: Phase 2 Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20101
20112
20121
20132
20141
20192
20202
20212
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Pfizer3
Gilead Sciences2
AbbVie (prior sponsor, Abbott)1
Bayer1
Boehringer Ingelheim1
Bristol-Myers Squibb1
CSL Behring1
Inversago Pharma Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies18
Renal Insufficiency, Chronic5
Diabetes Mellitus, Type 24
Albuminuria2
Diabetes Mellitus2
Diabetes Mellitus, Type 12
Kidney Diseases2
Bone Diseases1
Heart Failure1
Hypertension1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.